Publications 2016

1. Polymorphism in TGFB1 is associated with worse non-relapse mortality and overall survival after stem cell transplantation with unrelated donors. Arrieta-BolaƱos E, Mayor NP, Marsh SG, Madrigal JA, Apperley JF, Kirkland K, Mackinnon S, Marks DI, McQuaker G, Perry J, Potter MN, Russell NH, Thomson K, Shaw BE. Haematologica. 2016 Mar;101(3):382-90. doi: 10.3324/haematol.2015.134999. Epub 2015 Nov 26

2. BCSH/BSBMT/UK clinical virology network guideline: diagnosis and management of common respiratory viral infections in patients undergoing treatment for haematological malignancies or stem cell transplantation.Dignan FL, Clark A, Aitken C, Gilleece M, Jayakar V, Krishnamurthy P, Pagliuca A, Potter MN, Shaw B, Skinner R, Turner A, Wynn RF, Coyle P; Haemato-oncology Task Force of the British Committee for Standards in Haematology; British Society for Blood and Marrow Transplantation and the UK Clinical Virology Network. Br J Haematol. 2016 May;173(3):380-93. doi: 10.1111/bjh.14027. Epub 2016 Apr 7.

3. Allogeneic stem cell transplantation for refractory acute myeloid leukemia in pediatric patients: the UK experience. Patricia OHare, Giovanna lucchini, Michelle Cummins, Paul Veys, Mike Potter, Sarah Lawson, Ajay Vora, Robert Wynn, Andrew Peniket, Keiren Kirkland, Rachel Pearce, Julia Perry, and Persis Amrolia [Paper #BMT-2016-589R]